Action Point Financial Planning’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9
Closed -$2.53K – 1630
2026
Q2
$2.53K Buy
+9
New +$2.12K ﹤0.01% 2148

Other funds holding LGND

Action Point Financial Planning's LGND Position: Q3 2026 in Review

Action Point Financial Planning sold out of Ligand Pharmaceuticals (LGND) in Q3 2026, closing a stake of 9 shares — an estimated $2.53K sold.

Action Point Financial Planning first reported a position in LGND in Q2 2026 and held it in 1 quarter. The position peaked at $2.53K in Q2 2026. 433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Action Point Financial Planning reported no remaining Ligand Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 9 Ligand Pharmaceuticals shares in Q3 2026, an estimated $2.53K.
  • Action Point Financial Planning first reported a position in Ligand Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Ligand Pharmaceuticals position peaked at $2.53K in Q2 2026.
  • 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.